Esc, a compound with potential anticancer properties, promotes apoptosis and inhibits the proliferation of tumor cells

Esc, a compound with potential anticancer properties, promotes apoptosis and inhibits the proliferation of tumor cells. These effects are mediated by various molecular mechanisms involving different signaling pathways. In the PI3K/Akt pathway, Esc modulates the upstream molecule, IGF-1, to regulate the PI3K/Akt pathway in gastric cancer cells. Esc also targets downstream mTOR molecules to induce apoptosis and cell cycle arrest. Esc induces G1 phase cell cycle arrest by upregulating Ras, ERK1/2 and p27 KIP8, and activates MAPK signaling to induce apoptosis in colon and bladder cancer cells. Esc also regulates NF-κB in lung cancer cells. Esc activates the ARE pathway in pancreatic cancer cells by disrupting the Nrf2-KEAP1 interaction. Esc decreased Sp1 expression in oral squamous cell carcinoma cells and enhances TRAIL-induced apoptosis in oral cancer cells by upregulating DR5. Esc regulates the JAK/STAT3 pathway in ovarian and laryngeal cancers, leading to decreased expression of MMP2 and MMP9. In the Wnt/β-catenin pathway, Esc downregulates proteins such as c-Myc and cyclin D1, binds directly to β-catenin and inhibits the β-catenin/Tcf complex. Esc binds to hnRNPA1 in endometrial cancer, affecting Bcl-xl expression. These pathways highlight the diverse mechanisms through which Esc inhibits cancer proliferation and suggest its potential as a targeted therapy for various cancer types. Esc, esculetin; ERK, extracellular signal-regulated kinase; JAK, janus kinase; STAT3, signal transducer and activator of transcription-3; Nrf2, nuclear factor erythroid 2-related factor 2; MMP, matrix metalloproteinase; NF-κB, nuclear factor-κB; Sp1, specificity protein 1; DR, death receptor; MEK, mitogen-activated protein kinase kinase; hnRNPA1, heterogeneous nuclear ribonucleoprotein A1
Esc, a compound with potential anticancer properties, promotes apoptosis and inhibits the proliferation of tumor cells

Publication

Therapeutic potential of esculetin in various cancer types (Review) (2024) Mengying Liu, et al. Oncol Lett. 2024 Jul;28(1). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates IGF-1 IGF1 ncbigene_symbol IGF1 3479
Homo sapiens Primates Ras RAS famplex_relations KRAS 3845
Homo sapiens Primates Ras RAS famplex_relations HRAS 3265
Homo sapiens Primates Ras RAS famplex_relations NRAS 4893
Homo sapiens Primates JNK JNK ncbigene_synonym MAPK8 5599
Homo sapiens Primates JNK JNK famplex_relations MAPK9 5601
Homo sapiens Primates JNK JNK famplex_relations MAPK10 5602
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates p38 P38 ncbigene_synonym CRK 1398
Homo sapiens Primates p38 P38 ncbigene_synonym MAPK14 1432
Homo sapiens Primates p38 P38 ncbigene_synonym MAPK1 5594
Homo sapiens Primates p38 P38 ncbigene_synonym AIMP2 7965
Homo sapiens Primates p38 P38 ncbigene_synonym GRAP2 9402
Homo sapiens Primates p38 P38 ncbigene_synonym AHSA1 10598
Homo sapiens Primates p38 P38 ncbigene_synonym POLDIP2 26073
Homo sapiens Primates p38 P38 famplex_relations MAPK11 5600
Homo sapiens Primates p38 P38 famplex_relations MAPK12 6300
Homo sapiens Primates p38 P38 famplex_relations MAPK13 5603
Homo sapiens Primates MAPK MAPK famplex_relations MAPK3 5595
Homo sapiens Primates MEK MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates MEK MEK famplex_relations MAP2K1 5604
Homo sapiens Primates MEK MEK famplex_relations MAP2K2 5605
Homo sapiens Primates KEAP1 KEAP1 ncbigene_symbol KEAP1 9817
Homo sapiens Primates Nrf2 NRF2 ncbigene_synonym GABPA 2551
Homo sapiens Primates Nrf2 NRF2 ncbigene_synonym NFE2L2 4780
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates PERK PERK ncbigene_synonym EIF2AK3 9451
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates p21 P21 ncbigene_synonym CDKN1A 1026
Homo sapiens Primates p21 P21 ncbigene_synonym TCEAL1 9338
Homo sapiens Primates p21 P21 ncbigene_synonym NSG1 27065
Homo sapiens Primates p21 P21 ncbigene_synonym H3P16 644914
Homo sapiens Primates DR5 DR5 ncbigene_synonym TNFRSF10B 8795
Homo sapiens Primates JAK1 JAK1 ncbigene_symbol JAK1 3716
Homo sapiens Primates JAK2 JAK2 ncbigene_symbol JAK2 3717
Homo sapiens Primates MMP-2 MMP-2 ncbigene_synonym MMP2 4313
Homo sapiens Primates MMP-9 MMP-9 ncbigene_synonym MMP9 4318
Homo sapiens Primates B-catenin CTNNB1 ncbigene_symbol CTNNB1 1499
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates Sp1 SP1 ncbigene_symbol SP1 6667
Homo sapiens Primates Sp1 SP1 ncbigene_synonym PSG1 5669
Homo sapiens Primates Sp1 SP1 ncbigene_synonym DAND5 199699
Homo sapiens Primates Tcf TCF ncbigene_synonym HNF4A 3172
Homo sapiens Primates TRAIL TRAIL ncbigene_synonym TNFSF10 8743
Homo sapiens Primates cyclinD1 CCND1 ncbigene_symbol CCND1 595
Homo sapiens Primates hnRNPA1 HNRNPA1 ncbigene_symbol HNRNPA1 3178
Homo sapiens Primates c-myc C-MYC ncbigene_synonym MYC 4609

Chemical mentions

Word Match MeSH Name ChEBI
Ras RAS (1R)-N-(prop-2-yn-1-yl)indan-1-amine chebi:63620
MEK MEK butan-2-one chebi:28398
Esculetin esculetin esculetin chebi:490095
PERK PERK tetrachloroethene chebi:17300
Esculetin esculetin esculetin chebi:490095

Disease mentions

Word Match MeSH Name DOID
Cancer cancer cancer DOID:162